DOCSLIB.ORG

June 4–9, 2021

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

THE SCIENCE OF TOMORROW STARTS TODAY ATC2021 VirtualCONNECT atcmeeting.org JUNE 4–9, 2021 Registration Brochure & Scientific Program DISCOUNTED REGISTRATION DEADLINE MAY 5, 2021 #ATC2021VirtualConnect ATC2021 VirtualCONNECT All-New Enhanced Experience! We are excited to announce ATC 2021 Virtual Live Connect, an all-new, completely enhanced virtual Broadcast Dates: meeting experience. Gain immediate access to innovators in the field and have your voice heard June 4 – 9, 2021 through various types of interaction Real-Time Interactivity Over 200 Education Credit The 2021 program will provide ample and Contact Hours opportunities for real-time interactivity through: ATC provides CME, ANCC, ACPE, and ABTC credits/contact hours. Yearlong access allows • Live Video Discussions you to take advantage of the over 200 • Invigorating Q&A Discussions Post- credits/contact hours available. This is the Presentation most credits/contact hours ATC has ever been • Live Presentations by Abstract Presenters able to provide! • Engaging, Unconventional Networking Breaks Continue to check the ATC website for final • Live Symposia Presentations credit/contact hour details, www.atcmeeting.org. Mobile Responsive Access In-Depth Symposia Included You’ll be able to access Virtual Connect on-the-go, in Virtual Connect earn your education credit or contact hours, hear Included with ATC 2021 Virtual Connect are the latest innovations, and build your professional 9 In-Depth Symposia. These symposia will be network – all from the comfort and safety of your live broadcasted on Friday, June 4, 2021, and home or office. then available in the OnDemand format until June 3, 2022. Yearlong Access to OnDemand Content Time Zone Schedule of By registering to attend ATC 2021 Virtual Connect, Program – Eastern Time Zone you also will gain yearlong access to all Live The program schedule is built in Eastern Time Broadcast sessions available in an OnDemand Zone. The Virtual Connect platform will provide format. The access includes all Plenary options to display the program times in the Sessions, Rapid Fire Oral Abstracts, and Poster time zone you reside in or display in Eastern Presentations. The OnDemand Access is available Time Zone. until June 3, 2022. 2 2021 REGISTRATION BROCHURE & SCIENTIFIC PROGRAM ATC2021 VirtualCONNECT JUNE 4–9, 2021 THE SCIENCE OF TOMORROW STARTS TODAY | #ATC2021VirtualConnect About ATC The American Transplant Congress (ATC) is the joint annual CONTACT ATC Congress of the American Society of Transplant Surgeons (ASTS) and the American Society of Transplantation Congress (AST). ATC provides a forum for exchange of new scientific Headquarters American Transplant Congress and clinical information relevant to solid organ and 1120 Route 73, Suite 200 tissue transplantation and brings together transplant Mt. Laurel, NJ 08054 physicians, scientists, nurses, organ procurement Telephone: 856-439-0500 personnel, pharmacists, allied health professionals, and Fax: 856-439-0525 other transplant professionals. The educational offerings E-mail: [email protected] Website: atcmeeting.org provide attendees the opportunity to learn cutting-edge advances in research and promotes the exchange of Congress Team ideas and practice in the field of solid organ and tissue Shannon Fagan, CMP, HMCC transplantation. ATC is an annual Congress that welcomes Director of Meetings and Exhibits Direct Line: 856-642-4428 over 5,000 transplant professionals to present cutting-edge [email protected] science that covers all organ types and offers insight into Melanie Ryan the future of the field and patient care. Meetings, Exhibit and Sponsorship Relationship Manager About ASTS Direct Line: 856-380-6895 [email protected] The American Society of Transplant Surgeons represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. Natascha Williams ASTS advances the art and science of transplant surgery through Registration Manager & patient care, research, education, and advocacy. To learn more, visit Program Coordinator ASTS.org or email us at [email protected]. Direct Line: 856-380-6852 [email protected] About AST Christina Bertino Founded in 1982, the American Society of Transplantation Senior Marketing and (www. myAST.org) is dedicated to advancing the field of Communications Manager Direct Line: 856-380-6848 transplantation and improving patient care by promoting research, [email protected] education, advocacy, organ donation, and service to the community. The society, with over 4,000 members, is the largest organization of transplant professionals in North America. Other transplant organizations, policy makers, regulatory agencies, payors, academic institutions, and the general public look to the AST for guidance, research, and resources related to transplantation. 3 2021 REGISTRATION BROCHURE & SCIENTIFIC PROGRAM ATC2021 VirtualCONNECT JUNE 4–9, 2021 THE SCIENCE OF TOMORROW STARTS TODAY | #ATC2021VirtualConnect 2021 Program Planning Committee Executive Program Program Planning Committee Planning Committee Talia Baker, MD Diane McKay, MD University of Chicago Medicine Scripps Hospital CHAIRS Chicago, IL La Jolla, CA Linda Cendales, MD Duke University Medical Center Vikas Dharnidharka, MD, MPH Robert Montgomery, MD, PhD Durham, NC Washington University St. Louis NYU Langone Transplant Institute St. Louis, MO New York, NY Maryl Johnson, MD University of Wisconsin, Madison Christina Doligalski, PharmD Jordan Pober, MD, PhD Madison, WI University of North Carolina Yale University School of Medicine Chapel Hill, NC New Haven, CT CO-CHAIRS Matthew Levine, MD, PhD Amy Friedman, MD Raymond Razonable, MD University of Pennsylvania LiveOnNY Mayo Clinic College of Medicine & Science Philadelphia, PA New York, NY Rochester, MN Jesse Schold, PhD, M.Stat, M.Ed Samantha Halpern MSN, CRNP Elaine Reed, PhD Cleveland Clinic Foundation University of Pennsylvania University of California, Los Angeles Cleveland, OH Philadelphia, PA Los Angeles, CA CO-CHAIR ELECTS Roberto Hernandez, MD Benjamin Samstein, MD Linda Sher, MD University of Rochester, NY Weill Cornell Medical Center University of Southern California Rochester, NY New York, NY Los Angeles, CA Daniela Ladner MD, MPH Thomas Schiano, MD Andrew Adams, MD, PhD Northwestern University Mount Sinai Medical Center University of Minnesota Chicago, IL New York, NY Minneapolis, MN Didier Mandelbrot, MD Laurie Snyder, MD, MHS UW Health Duke University Madison, WI Durham, NC Christopher Marsh, MD Parisa Vagefi, MD Scripps Clinic Medical Group University of Texas Southwestern La Jolla, CA Dallas, TX Statement of Need Purpose of Activity The field of solid organ and tissue transplantation is ATC educational offerings will provide transplant professionals continuously changing and developing. With the rapid a learning environment designed to address their professional advances in transplantation research and medicine, transplant practice gaps through a variety of learning formats that will professionals require ongoing educational opportunities to encourage the exchange of new scientific concepts, emerging stay current, and to maintain and improve their knowledge, technologies, and medical advances. Learners will engage competence, and performance. Thus, this educational forum in interactive discussions, case presentations, workshops, will generate activities and interventions that are designed to and other activities designed to improve competence and change and update the learners’ competence, performance, professional and patient outcomes. and patient outcomes in the field of solid organ and tissue transplantation. The educational content of this meeting was developed by experts in scientific and clinical transplantation and was determined by rigorous assessment of learners’ feedback from prior meetings, expert faculty assessment, literature review, medical practice, and new medical technology. 4 2021 REGISTRATION BROCHURE & SCIENTIFIC PROGRAM ATC2021 VirtualCONNECT JUNE 4–9, 2021 THE SCIENCE OF TOMORROW STARTS TODAY | #ATC2021VirtualConnect ASTS Council AST Board 2020 – 2021 2020 – 2021 President President Marwan S. Abouljoud, MD, FACS, MMM Richard Formica, MD, FAST President-Elect President-Elect A. Osama Gaber, MD, FACS John S. Gill, MD, MS, FAST Immediate Past President Past President Lloyd E. Ratner, MD, MPH Emily Blumberg, MD, FAST Past President Secretary Dixon B. Kaufman, MD, PhD Deepali Kumar, MD, MSc Secretary Treasurer Ginny L. Bumgardner, MD, PhD Josh Levitsky, MD, MS Treasurer Councilors-at Large William C. Chapman, MD, FACS Lisa Potter, PharmD, FAST Jonathan Maltzman, MD, PhD, FAST Councilors-at-Large Howie Gebel, PhD Michael J. Englesbe, MD Roy Bloom, MD Julie K. Heimbach, MD Betsy Verna, MD, MSc, FAST Debra L. Sudan, MD Jim Rodrigue, PhD, FAST Matthew Cooper, MD Burnett “Beau” Kelly, MD, MBA, FACS, FAST Ryutaro Hirose, MD Sean Pinney, MD, FACC Kenneth Washburn, MD Linda Ohler, MSN, RN, CCTC, FAAN, FAST Kenneth A. Andreoni, MD Devin E. Eckhoff, MD Chief Executive Officer Irene K. Kim, MD Shandie Covington, FAST Associate Councilor Ashley H. Seawright, DNP, ACNP-BC Executive Director Maggie Kebler-Bullock, CFRE ASTS National Office AST National Office 1401 S. Clark Street, Suite 1120 1120 Route 73, Suite 200 Arlington, VA 22202 Mt. Laurel, NJ 08054 Telephone: 703-414-7870 Telephone: 856-439-9986 Fax: 703-414-7874 Fax: 856-581-9604 Email: [email protected] Email: [email protected] Website: www.asts.org Website: www.myAST.org 5 2021 REGISTRATION BROCHURE & SCIENTIFIC PROGRAM ATC2021 VirtualCONNECT
Recommended publications
  • WO 2017/048702 Al

    WO 2017/048702 Al

    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date W O 2017/048702 A l 2 3 March 2017 (23.03.2017) P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every C07D 487/04 (2006.01) A61P 35/00 (2006.01) kind of national protection available): AE, AG, AL, AM, A61K 31/519 (2006.01) AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, (21) International Application Number: DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, PCT/US20 16/05 1490 HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, (22) International Filing Date: KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, 13 September 2016 (13.09.201 6) MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (25) Filing Language: English SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, (26) Publication Language: English TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (30) Priority Data: 62/218,493 14 September 2015 (14.09.2015) US (84) Designated States (unless otherwise indicated, for every 62/218,486 14 September 2015 (14.09.2015) US kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, (71) Applicant: INFINITY PHARMACEUTICALS, INC.
  • Project Protocol

    Project Protocol

    CADTH Health Technology Assessment June 2016 (Update Drugs for the management of rheumatoid May 2017) arthritis: clinical evaluation – project protocol PROSPERO Registration Number: CRD42016041498 1 Cite as: Drugs for the management of rheumatoid arthritis: clinical evaluation – project protocol. Ottawa: CADTH; 2016 Jun; updated 2017 April. This report is prepared by the Canadian Agency for Drugs and Technologies in Health (CADTH) in collaboration with the Canadian Institutes of Health Research (CIHR) Drug Safety and Effectiveness Network (DSEN). This report contains a comprehensive review of existing public literature, studies, materials, and other information and documentation (collectively the “source documentation”) available to CADTH at the time it was prepared, and its creation was guided by expert input and advice throughout its preparation. The information in this report is intended to help health care decision-makers, patients, health care professionals, health systems leaders, and policy-makers make well-informed decisions and thereby improve the quality of health care services. The information in this report should not be used as a substitute for the application of clinical judgment in respect to the care of a particular patient or other professional judgment in any decision-making process, nor is it intended to replace professional medical advice. While CADTH has taken care in the preparation of this report to ensure that its contents are accurate, complete, and up-to-date, CADTH does not make any guarantee to that effect. CADTH is not responsible for any errors or omissions or injury, loss, or damage arising from or as a result of the use (or misuse) of any information contained in or implied by the information in this report.
  • State Operations Manual Appendix X – Guidance to Surveyors: Organ Transplant Programs

    State Operations Manual Appendix X – Guidance to Surveyors: Organ Transplant Programs

    State Operations Manual Appendix X – Guidance to Surveyors: Organ Transplant Programs Table of Contents (Rev. 200, Issued: 02-21-20) Transmittals for Appendix X Part I – The Standard Organ Transplant Program Survey Protocol I. Introduction II. Survey Protocol Tasks Task 1 - Pre-survey: off-site Preparation Task 2 - Entrance Activities Task 3 - Sample Selection Task 4 - Tracer for Selected Patients and Living Donors including Observations of Care, Interviews and Medical Record Review Task 5 – Administrative Review Task 6 – Personnel Record Review (If Indicated) Task 7 – Pre-exit Task 8 – Exit Conference Task 9 - Post Survey Activities III. Alternate Survey Protocol: Pediatric Heart Program Task 1 - Pre-survey: off-site Preparation Task 2 - Entrance Activities Task 3 - Sample Selection Task 4 – Review of Transplant Patient Medical Records Task 5 – Staff Interview Task 6 – Personnel Record Review Task 7 – Administrative Review Task 8 – Pre-exit Task 9 – Exit Conference Task 10 - Post Survey Activities Part II – Interpretive Guidelines for Organ Transplant Surveys 42 C.F.R. 482.72 OPTN Membership 42 C.F.R. 482.74 Notification to CMS 42 C.F.R. 482.76 Pediatric Transplants 42 C.F.R. 482.78 Emergency preparedness for Transplant Programs 42 C.F.R. 482.80 Data Submission, Clinical Experience and Outcome Requirements for Initial Approval 42 C.F.R. 482.82 Data Submission, Clinical Experience and Outcome Requirements Re-approval 42 C.F.R. 482.90 Patient and Living Donor Selection 42 C.F.R. 482.92 Organ Recovery and Receipt 42 C.F.R. 482.94 Patient and Living Donor Management 42 C.F.R.
  • Partnering with Your Transplant Team the Patient’S Guide to Transplantation

    Partnering with Your Transplant Team the Patient’S Guide to Transplantation

    Partnering With Your Transplant Team The Patient’s Guide to Transplantation U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration This booklet was prepared for the Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation by the United Network for Organ Sharing (UNOS). PARTNERING WITH YOUR TRANSPLANT TEAM THE PATIENT’S GUIDE TO TRANSPLANTATION U.S. Department of Health and Human Services Health Resources and Services Administration Public Domain Notice All material appearing in this document, with the exception of AHA’s The Patient Care Partnership: Understanding Expectations, Rights and Responsibilities, is in the public domain and may be reproduced without permission from HRSA. Citation of the source is appreciated. Recommended Citation U.S. Department of Health and Human Services (2008). Partnering With Your Transplant Team: The Patient’s Guide to Transplantation. Rockville, MD: Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation. DEDICATION This book is dedicated to organ donors and their families. Their decision to donate has given hundreds of thousands of patients a second chance at life. CONTENTS Page INTRODUCTION.........................................................................................................................1 THE TRANSPLANT EXPERIENCE .........................................................................................3 The Transplant Team .......................................................................................................................4
  • A PILOT RANDOMIZED CONTROLLED TRIAL of DE NOVO BELATACEPT-BASED IMMUNOSUPPRESSION in LUNG TRANSPLANTATION Howard J. Huang, MD Ra

    A PILOT RANDOMIZED CONTROLLED TRIAL of DE NOVO BELATACEPT-BASED IMMUNOSUPPRESSION in LUNG TRANSPLANTATION Howard J. Huang, MD Ra

    A PILOT RANDOMIZED CONTROLLED TRIAL OF DE NOVO BELATACEPT-BASED IMMUNOSUPPRESSION IN LUNG TRANSPLANTATION Howard J. Huang, MD Ramsey R. Hachem, MD Study ID: IM103-387 Draft: v 6.0 Date: 8 December 2017 ! 1 TABLE OF CONTENTS Section Page 1. List of Abbreviations 3 2. Protocol Summary 4 3. Study Schematic 4 4. Key Roles 5 5. Introduction 6 6. Objectives and Purpose 7 7. Study Design and Endpoints 7 8. Study Enrollment 8 9. Study Agent 11 10. Study Procedures and Schedule 11 11. Safety Considerations 13 12. Statistical Considerations 18 13. References 19 ! 2 LIST OF ABBREVIATIONS ACR Acute Cellular Rejection AE Adverse Event AMR Antibody-Mediated Rejection ATG Anti-Thymocyte Globulin ATS American Thoracic Society BAL Bronchoalveolar Lavage BELA Belatacept BMS Bristol-Myers Squibb BOS Bronchiolitis Obliterans Syndrome CARV Community-Acquired Respiratory Virus/Viral CBC Complete Blood Counts CFR Code of Federal Regulations CIP Cellular Immunophenotyping CKD Chronic Kidney Disease CLAD Chronic Lung Allograft Dysfunction CMP Comprehensive Metabolic Panel CMV Cytomegalovirus CNI Calcineurin Inhibitor DCC Data Coordinating Center DSA Donor-Specific HLA Antibodies DSMB Data Safety and Monitoring Board EBV Epstein-Barr Virus ECLS Extra-Corporeal Life Support ECMO Extra-Corporeal Membrane Oxygenation FOB Fiberoptic Bronchoscopy GCP Good Clinical Practice HIV Human Immunodeficiency Virus HLA Human Leukocyte Antigens HSV Herpes Simplex Virus IgG Immunoglobulin G IP Investigational Product IRB Institutional Review Board IS Immunosuppression ISHLT International
  • Flesh Is Heir

    Flesh Is Heir

    cover story 125 Years of r e m o v i n g a n d Preventing t h e i l l s t o w h i c h fleSh is heiR b y b arbara I. Paull, e r I c a l l o y d , e d w I n K I ester Jr., J o e m ik s c h , e l a I n e v I t o n e , c h u c K s ta r e s I n I c , a n d sharon tregas ki s lthough the propriety of establishing a medical school here has been sharply questioned by some, “ we will not attempt to argue the question. Results will determine whether or not the promoters of the enterprise were mistaken in their judgment Aand action. The city, we think, offers ample opportunity for all that is desirable in a first-class medical school, and if you will permit me to say it, the trustees and faculty propose to make this a first-class school.” —John Milton Duff, MD Professor of Obstetrics, September 1886 More than three decades after the city’s first public hospital was established, after exhausting efforts toward a joint charter, Pittsburgh physicians founded an indepen- dent medical college, opening its doors in September 1886. This congested industrial city—whose public hospital then performed more amputations and saw more fatal typhoid-fever cases per capita than any other in the country—finally would have its own pipeline of new physicians for its rising tide of diseased and injured brakemen, domestics, laborers, machinists, miners, and steelworkers from around the world, as well as the families of its merchants, professionals, and industry giants.
  • Djokovic, Kenin Defend Titles but No Federer at Unique Australian Open

    Djokovic, Kenin Defend Titles but No Federer at Unique Australian Open

    Sports Sunday, February 7, 2021 13 beIN SPORTS to broadcast Djokovic, Kenin defend titles but no Australian Open exclusively Federer at unique Australian Open across MENA DPA TRIBUNE NEWS NETWORK BERLIN The coronavirus has made the Australian Open a massive challenge DOHA THE contrast to 2020 could for tennis players and organizers alike but the best in the world – BEIN MEDIA GROUP, the hardly be starker when the global sports and entertain- Australian Open starts Mon- ment broadcaster and its day with Novak Djokovic and most of them – are now ready to take to the court in Melbourne. flagship sports channel beIN Sofia Kenin defending the ti- SPORTS will broadcast the tles they won 13 months ago in long awaited 2021 Australian Melbourne. Open live and exclusively for Those wins heralded the its viewers and subscribers start of a tennis season which across the Middle East and would soon be halted by the North Africa (MENA) – in- coronavirus pandemic and cluding exclusive footage of then resumed in limited fash- Tunisian star Ons Jabeur and ion only months later, after Egyptian talent Mayar Sherif. the cancellation of Wimble- The date for the start of don, and with a completely re- the 2021 Australian Open was worked schedule. previously scheduled to begin The global health situation in January but was postponed has forced Australian Open to February (8-21) due to the organizers to delay their tour- COVID-19 pandemic. The nament from its usual slot by 2021 Australian Open men’s three weeks from the intended qualifying was successfully January 18 start.
  • 35Th Anniversary Vol

    35Th Anniversary Vol

    Published for Members of the American Society of Transplant Surgeons 35th Anniversary Vol. XV, No. 1 Summer 2009 President’s Letter 4 Member News 6 Regulatory & Reimbursement 8 Legislative Report 10 OPTN/UNOS Corner 12 35th Anniversary of ASTS 14 Winter Symposium 18 Chimera Chronicles 19 American Transplant Congress 2009 20 Beyond the Award 23 ASTS Job Board 26 Corporate Support 27 Foundation 28 Calendar 29 New Members 30 www.asts.org ASTS Council May 2009–May 2010 PRESIDENT TREASURER Charles M. Miller, MD (2011) Robert M. Merion, MD (2010) Alan N. Langnas, DO (2012) Cleveland Clinic Foundation University of Michigan University of Nebraska Medical Center 9500 Euclid Avenue, Mail Code A-110 2922 Taubman Center PO Box 983280 Cleveland, OH 44195 1500 E. Medical Center Drive 600 South 42nd Street Phone: 216 445.2381 Ann Arbor, MI 48109-5331 Omaha, NE 68198-3280 Fax: 216 444.9375 Phone: 734 936.7336 Phone: 402 559.8390 Email: [email protected] Fax: 734 763.3187 Fax: 402 559.3434 Peter G. Stock, MD, PhD (2011) Email: [email protected] Email: [email protected] University of California San Francisco PRESIDENT -ELECT COUNCILORS -AT -LARGE Department of Surgery, Rm M-884 Michael M. Abecassis, MD, MBA (2010) Richard B. Freeman, Jr., MD (2010) 505 Parnassus Avenue Northwestern University Tufts University School of Medicine San Francisco, CA 94143-0780 Division of Transplantation New England Medical Center Phone: 415 353.1551 675 North St. Clair Street, #17-200 Department of Surgery Fax: 415 353.8974 Chicago, IL 60611 750 Washington Street, Box 40 Email: [email protected] Phone: 312 695.0359 Boston, MA 02111 R.
  • Allotransplantation, from Dream to Realty

    Allotransplantation, from Dream to Realty

    allotransplantation, froM dreaM to realtY DENYS MONTANDON, MD Switzerland In the vegetal world, grafting can be defined as the natural or deliberate fusion Later, St. John obtained by praying his cut hand, touched it to his wrist and of plant parts so that vascular continuity is established between them, and kneeled in front of the icon of the Virgin Mary. After a long prayer, he felt thus the resulting genetically composite organism functions as a single plant. asleep and dreamed of the Virgin Mary who Vegetal grafts have been performed since antiquity, particularly around the told him “Your hand is healed because you Mediterranean Basin. No wonder, the idea of grafting a portion of tissue, an wrote in defense of God.” When St. John organ or a limb from one individual to another has been a conscious or an awoke, he saw his cured hand and to express unconscious dream for centuries. We are speaking here not only of implanting his gratitude to the Virgin Mary he ordered a foreign body in a living creature, but to graft living material which will be to put on the icon a silver copy of the cut re-vascularized so as to become an integral part of the recipient host. hand. That’s why the icon is called the Three Handed Virgin. (Fig. 3) myThS ANd mIrACleS Hybrid monsters made of different ANeCdoTeS animal or human parts are not rare in During the Renaissance, the possibility of the myths of several civilizations. One reconstructing a nose with the person’s of the best known in Greek mythology own flesh, as initiated by the Branca family is the Centaur Chiron who had the in Catania (Sicily), and later described and Figure3 - Three Hands Icon of Virgin head and torso of a man and the illustrated in detail by Gaspare Tagliacozzi Mary body of a horse (Fig.
  • 2021 Hydropower Status Report Sector Trends and Insights

    2021 Hydropower Status Report Sector Trends and Insights

    2021 Hydropower Status Report Sector trends and insights | 1 Contents REGISTER FOR THE VIRTUAL Foreword 4 Executive summary 5 Hydropower installed capacity in 2020 7 Hydropower growth in context 8 Where was capacity added in 2020? 9 Regional developments 10 Sector developments 12 Feature: A defining year for pumped storage 12 Clean energy systems 14 Finance and modernisation 16 Water and climate change 18 Sustainability assessments 19 The planet’s premier hydropower event Feature: The new global sustainability standard 20 is now online and open to all Regions in focus 22 Registration has opened for the 2021 World North and Central America 22 Hydropower Congress, the globe’s premier 7-24 SEPTEMBER 2021 South America 26 gathering of influencers and innovators REGISTER NOW FOR FREE dedicated to advancing sustainable Europe 30 HYDROPOWER.ORG/CONGRESS hydropower. Africa 34 For the first time ever, access to the World South and Central Asia 38 Hydropower Congress is free of charge and East Asia and Pacific 42 open to all. Virtual events will be broadcast Data tables: capacity and generation 2020 46 online across multiple timezones, with video on-demand services available for all registrants. Hosted by With support from Hosting partner Organised by Over 150 speakers will address more than 30 virtual events over three weeks between 7-24 September 2021. Strategic partners Supporting partners Event sponsor 2 | International Hydropower Association | Hydropower Status Report 2021 | |1 1 We are the voice of sustainable hydropower Secure hydropower’s place in the energy transition by joining the International Hydropower Association today The International Hydropower Association When delivered responsibly, hydropower offers (IHA) represents organisations and individuals clean, affordable and reliable electricity, while committed to sustainable hydropower.
  • Announcer Andy Taylor. 2021 Qatar Total Open Champions And

    Announcer Andy Taylor. 2021 Qatar Total Open Champions And

    MOST QATAR TOTAL OPEN TITLES MOST QATAR TOTAL OPEN FINALS 2 - Petra Kvitova (CZE) 3 - Petra Kvitova (CZE) 2 - Victoria Azarenka (BLR) 3 - Victoria Azarenka (BLR) 2 - Maria Sharapova (RUS) 2 - Simona Halep (ROU) 2 - Anastasia Myskina (RUS) 2 - Caroline Wozniacki (DEN) 2 - Vera Zvonareva (RUS) 2 - Maria Sharapova (RUS) 2 - Svetlana Kuznetsova (RUS) 2 - Anastasia Myskina (RUS) Qatar Total Open - Singles Champions and Finalists LEVEL YEAR CHAMPION Titles Finals FINALIST Titles Finals WTA 500 2021 Petra Kvitova (CZE) 2 3 Garbiñe Muguruza (ESP) 0 2 Premier 5 2020 Aryna Sabalenka (BLR) 1 1 Petra Kvitova (CZE) 1 2 Premier 2019 Elise Mertens (BEL) 1 1 Simona Halep (ROU) 1 2 Premier 5 2018 Petra Kvitova (CZE) 1 1 Garbiñe Muguruza (ESP) 0 1 Premier 2017 Karolina Pliskova (CZE) 1 1 Caroline Wozniacki (DEN) 0 2 Premier 5 2016 Carla Suarez Navarro (ESP) 1 1 Jelena Ostapenko (LAT) 1 1 Premier 2015 Lucie Safarova (CZE) 1 1 Victoria Azarenka (BLR) 2 3 Premier 5 2014 Simona Halep (ROU) 1 1 Angelique Kerber (GER) 0 1 Premier 5 2013 Victoria Azarenka (BLR) 2 2 Serena Williams (USA) 0 1 Premier 5 2012 Victoria Azarenka (BLR) 1 1 Sam Stosur (AUS) 0 1 Premier 2011 Vera Zvonareva (RUS) 1 2 Caroline Wozniacki (DEN) 0 1 WTA Finals 2010 Kim Clijsters (BEL) Caroline Wozniacki (DEN) WTA Finals 2009 Serena Williams (USA) Venus Williams (USA) WTA Finals 2008 Venus Williams (USA) Vera Zvonareva (RUS) Tier I 2008 Maria Sharapova (RUS) 2 2 Vera Zvonareva (RUS) 0 1 Tier II 2007 Justin Henin (BEL) 1 1 Svetlana Kuznetsova (RUS) 0 2 Tier II 2006 Nadia Petrova (RUS) 1 1 Amelie Mauresmo (FRA) 0 1 Tier II 2005 Maria Sharapova (RUS) 1 1 Alicia Molik (AUS) 0 1 Tier II 2004 Anastasia Myskina (RUS) 2 2 Svetlana Kuznetsova (RUS) 0 1 Tier III 2003 Anastasia Myskina (RUS) 1 1 Elena Likhovtseva (RUS) 0 1 Tier III 2002 Monica Seles (USA) 1 1 Tamarine Tanasugarn (THA) 0 1 Tier III 2001 Martina Hingis (SUI) 1 1 Sandrine Testud (FRA) 0 1 Doha hosted the WTA Finals | In 2009 and 2010, the Qatar Total Open was not held.
  • Natera Announces Publication of Analytical Validation Study Demonstrating Superior Precision of Its Kidney Transplant Rejection Assay

    Natera Announces Publication of Analytical Validation Study Demonstrating Superior Precision of Its Kidney Transplant Rejection Assay

    Natera Announces Publication of Analytical Validation Study Demonstrating Superior Precision of Its Kidney Transplant Rejection Assay February 22, 2019 Core Technology Delivers Superior Analytical Performance, Underpins Outstanding Clinical Performance SAN CARLOS, Calif., Feb. 22, 2019 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a leader in cell-free DNA, today announced analytical validation study results to be published online in the journal Transplantation demonstrating the superior performance of its donor-derived cell-free DNA (dd-cfDNA) test for detecting active rejection in kidney transplant recipients.1 The study showed superior assay precision with coefficient of variation up to five times better than previously published studies.1,2 Natera's analytical validation was based on the analysis of 1,064 replicate samples from both related and non-related donor-recipient pairs. Conducted according to rigorous guidelines from the Clinical & Laboratory Standards Institute, the validation study measured key properties of the assay, including lower limit of detection, linearity, and precision. The assay's precision was particularly strong, showing a coefficient of variation up to five times better than that of a competitive dd-cfDNA assay (1.85% vs. 9.2% within run; 1.99% vs. 4.5% across runs) in repeatability and reproducibility studies.1,2 Previously published analytical studies using other dd-cfDNA assays did not include related donor-recipient cases (such as parents or siblings), which is notable given the technical challenge of differentiating DNA patterns from close relatives. It has been estimated that 52 percent of live kidney donations originate from biologically related donors.3 Natera has leveraged its deep experience using single-nucleotide polymorphism (SNP)-based methods to analyze fetal DNA in maternal blood to achieve high accuracy in these cases.